Ignite Creation Date:
2025-12-24 @ 10:09 PM
Ignite Modification Date:
2026-02-21 @ 10:11 PM
Study NCT ID:
NCT04048135
Status:
COMPLETED
Last Update Posted:
2024-04-02
First Post:
2019-08-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Multiple Ascending Dose Study of Pegozafermin in Participants With Biopsy Confirmed Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) and at High Risk of NASH
Sponsor:
89bio, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
BIO89-100-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |